this post was submitted on 09 Dec 2023
480 points (97.4% liked)
Technology
59390 readers
4323 users here now
This is a most excellent place for technology news and articles.
Our Rules
- Follow the lemmy.world rules.
- Only tech related content.
- Be excellent to each another!
- Mod approved content bots can post up to 10 articles per day.
- Threads asking for personal tech support may be deleted.
- Politics threads may be removed.
- No memes allowed as posts, OK to post as comments.
- Only approved bots from the list below, to ask if your bot can be added please contact us.
- Check for duplicates before posting, duplicates may be removed
Approved Bots
founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
This is the best summary I could come up with:
WASHINGTON (AP) — The Biden administration is putting pharmaceutical companies on notice, warning them that if the price of certain drugs is too high, the government might cancel their patent protection and allow rivals to make their own versions.
Under a plan announced Thursday, the government would consider overriding the patent for high-priced drugs that have been developed with the help of taxpayer money and letting competitors make them in hopes of driving down the cost.
With health care costs in mind, the administration also sent a warning Thursday to private equity firms that have been buying up and gutting hospitals and physician practices around the country, then selling for a profit.
While only a minority of drugs on the market relied so heavily on taxpayer dollars, the threat of a government “march-in” on patents will make many pharmaceutical companies think twice, said Jing Luo, a professor of medicine at University of Pittsburgh.
The pharmaceutical lobby immediately pushed back on Biden’s announcement, arguing the White House’s interpretation of the law is inaccurate and their plan will stifle drug research and development.
“This would be yet another loss for American patients who rely on public-private sector collaboration to advance new treatments and cures,” said Megan Van Etten, a spokesperson for the Pharmaceutical Research and Manufacturers of America, or PhRMA.
The original article contains 757 words, the summary contains 218 words. Saved 71%. I'm a bot and I'm open source!